Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Románia

4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Where

  Brasov, Bucharest, Cluj-Napoca, Sibiu

  Életkor

  18 év and over

  People

  1046 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06717347 · EU 2024-515566-13-00
• 1. fázisTaking people
  Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

  Where

  Bucharest, Cluj-Napoca

  Életkor

  18 év and over

  People

  85 worldwide

  Run by

  Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

  See details and how to joinNCT06980116 · EU 2024-516869-36-00
• 1. fázisTaking people
  Study of SGR-1505 in Mature B-Cell Neoplasms

  Where

  Bucharest, Cluj-Napoca

  Életkor

  18 év and over

  People

  98 worldwide

  Run by

  Schrödinger, Inc.

  See details and how to joinNCT05544019 · EU 2023-505204-34-00
• 2. fázisTaking people
  DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  Where

  Bucharest, Cluj-Napoca

  Életkor

  18 év and over

  People

  102 worldwide

  Run by

  ImmunoVaccine Technologies, Inc. (IMV Inc.)

  See details and how to joinNCT04920617